Previous close | 3.7500 |
Open | 3.1400 |
Bid | 3.2000 |
Ask | 3.3500 |
Strike | 17.00 |
Expiry date | 2024-07-05 |
Day's range | 3.1200 - 3.2700 |
Contract range | N/A |
Volume | |
Open interest | 34 |
On June 18, 2024, James Young, Director at Novavax Inc (NASDAQ:NVAX), executed a sale of 7,500 shares of the company. Following this transaction, the insider now owns 69,260 shares of Novavax Inc. Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.
Novavax stock seesawed on June 6 after the FDA assigned an April review date for its Covid vaccine. Is NVAX stock a buy right now?
In the most recent trading session, Novavax (NVAX) closed at $14.06, indicating a +1.99% shift from the previous trading day.